Global Female Contraceptives Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 104

Report ID: 2122

Birth control medicine used by female.
Need to avoid unwanted pregnancies, especially among the teenage women, is one of the major drivers for this market. Government initiatives, promoting the use of contraceptives to avoid unnecessary births, and health benefits from using contraceptives, have also been important factors, instrumental in market growth.
In 2018, the global Female Contraceptives market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Female Contraceptives status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Female Contraceptives development in United States, Europe and China.

The key players covered in this study
Bayer
Mayer Laboratories
Pfizer
Mylan
Teva
Merck
Johnson & Johnson
Lupin Pharmaceuticals
Female Health Company
Fuji Latex

Market segment by Type, the product can be split into
Contraceptive Drugs
Contraceptive Devices

Market segment by Application, split into
Personal use
Hospital

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Female Contraceptives status, future forecast, growth opportunity, key market and key players.
To present the Female Contraceptives development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Female Contraceptives are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Female Contraceptives Market Size Growth Rate by Type (2014-2025)
1.4.2 Contraceptive Drugs
1.4.3 Contraceptive Devices
1.5 Market by Application
1.5.1 Global Female Contraceptives Market Share by Application (2014-2025)
1.5.2 Personal use
1.5.3 Hospital
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Female Contraceptives Market Size
2.2 Female Contraceptives Growth Trends by Regions
2.2.1 Female Contraceptives Market Size by Regions (2014-2025)
2.2.2 Female Contraceptives Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Female Contraceptives Market Size by Manufacturers
3.1.1 Global Female Contraceptives Revenue by Manufacturers (2014-2019)
3.1.2 Global Female Contraceptives Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Female Contraceptives Market Concentration Ratio (CR5 and HHI)
3.2 Female Contraceptives Key Players Head office and Area Served
3.3 Key Players Female Contraceptives Product/Solution/Service
3.4 Date of Enter into Female Contraceptives Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Female Contraceptives Market Size by Type (2014-2019)
4.2 Global Female Contraceptives Market Size by Application (2014-2019)

5 United States
5.1 United States Female Contraceptives Market Size (2014-2019)
5.2 Female Contraceptives Key Players in United States
5.3 United States Female Contraceptives Market Size by Type
5.4 United States Female Contraceptives Market Size by Application

6 Europe
6.1 Europe Female Contraceptives Market Size (2014-2019)
6.2 Female Contraceptives Key Players in Europe
6.3 Europe Female Contraceptives Market Size by Type
6.4 Europe Female Contraceptives Market Size by Application

7 China
7.1 China Female Contraceptives Market Size (2014-2019)
7.2 Female Contraceptives Key Players in China
7.3 China Female Contraceptives Market Size by Type
7.4 China Female Contraceptives Market Size by Application

8 Japan
8.1 Japan Female Contraceptives Market Size (2014-2019)
8.2 Female Contraceptives Key Players in Japan
8.3 Japan Female Contraceptives Market Size by Type
8.4 Japan Female Contraceptives Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Female Contraceptives Market Size (2014-2019)
9.2 Female Contraceptives Key Players in Southeast Asia
9.3 Southeast Asia Female Contraceptives Market Size by Type
9.4 Southeast Asia Female Contraceptives Market Size by Application

10 India
10.1 India Female Contraceptives Market Size (2014-2019)
10.2 Female Contraceptives Key Players in India
10.3 India Female Contraceptives Market Size by Type
10.4 India Female Contraceptives Market Size by Application

11 Central & South America
11.1 Central & South America Female Contraceptives Market Size (2014-2019)
11.2 Female Contraceptives Key Players in Central & South America
11.3 Central & South America Female Contraceptives Market Size by Type
11.4 Central & South America Female Contraceptives Market Size by Application

12 International Players Profiles
12.1 Bayer
12.1.1 Bayer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Female Contraceptives Introduction
12.1.4 Bayer Revenue in Female Contraceptives Business (2014-2019)
12.1.5 Bayer Recent Development
12.2 Mayer Laboratories
12.2.1 Mayer Laboratories Company Details
12.2.2 Company Description and Business Overview
12.2.3 Female Contraceptives Introduction
12.2.4 Mayer Laboratories Revenue in Female Contraceptives Business (2014-2019)
12.2.5 Mayer Laboratories Recent Development
12.3 Pfizer
12.3.1 Pfizer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Female Contraceptives Introduction
12.3.4 Pfizer Revenue in Female Contraceptives Business (2014-2019)
12.3.5 Pfizer Recent Development
12.4 Mylan
12.4.1 Mylan Company Details
12.4.2 Company Description and Business Overview
12.4.3 Female Contraceptives Introduction
12.4.4 Mylan Revenue in Female Contraceptives Business (2014-2019)
12.4.5 Mylan Recent Development
12.5 Teva
12.5.1 Teva Company Details
12.5.2 Company Description and Business Overview
12.5.3 Female Contraceptives Introduction
12.5.4 Teva Revenue in Female Contraceptives Business (2014-2019)
12.5.5 Teva Recent Development
12.6 Merck
12.6.1 Merck Company Details
12.6.2 Company Description and Business Overview
12.6.3 Female Contraceptives Introduction
12.6.4 Merck Revenue in Female Contraceptives Business (2014-2019)
12.6.5 Merck Recent Development
12.7 Johnson & Johnson
12.7.1 Johnson & Johnson Company Details
12.7.2 Company Description and Business Overview
12.7.3 Female Contraceptives Introduction
12.7.4 Johnson & Johnson Revenue in Female Contraceptives Business (2014-2019)
12.7.5 Johnson & Johnson Recent Development
12.8 Lupin Pharmaceuticals
12.8.1 Lupin Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Female Contraceptives Introduction
12.8.4 Lupin Pharmaceuticals Revenue in Female Contraceptives Business (2014-2019)
12.8.5 Lupin Pharmaceuticals Recent Development
12.9 Female Health Company
12.9.1 Female Health Company Company Details
12.9.2 Company Description and Business Overview
12.9.3 Female Contraceptives Introduction
12.9.4 Female Health Company Revenue in Female Contraceptives Business (2014-2019)
12.9.5 Female Health Company Recent Development
12.10 Fuji Latex
12.10.1 Fuji Latex Company Details
12.10.2 Company Description and Business Overview
12.10.3 Female Contraceptives Introduction
12.10.4 Fuji Latex Revenue in Female Contraceptives Business (2014-2019)
12.10.5 Fuji Latex Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details